City-Wide Behavioural Neurology Rounds - R. Blesa: The role of biomarkers in the pharmacological management of Alzheimer’s disease

Download or view the Presentation Flyer in PDF here.

Presenter:
Rafael Blesa, MD
Professor of Neurology, Chief of Memory & Alzheimer’s Disease Unit,
Head & Director of the Neurology Department,
Hospital de la Santa Crue i Sant Pau, Spain

8:00am - 8:45am: Presentation
8:45am - 9:00am: Interactive session

Location:
Baycrest Hospital
Ben and Hilda Katz Building
2nd floor
Classrooms ABC

Learning Objectives:

1. Recognize the role of different biomarkers in the diagnosis and management of Alzheimer’s disease.
2. Briefly summarize the current state of pharmacological management in Alzheimer’s disease.
3. Discuss the future of pharmacological management in Alzheimer’s disease.

This event will be videoconferenced from Baycrest to the following participating sites:

• Sunnybrook Health Sciences Centre Room A450
• Toronto Rehabilitation Institute
• St. Michael’s Hospital
• Bridgepoint Health
• Bloorview Kids Rehab
• The Royal Victoria Hospital, Barrie
  

This event is an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

We gratefully acknowledge educational grants from Lundbeck Canada Inc., Novartis Inc., and Pfizer Canada which support these rounds

• Rounds are Restricted to Health Care Professionals